These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 420953)

  • 1. [Induction chemotherapy in high risk breast cancer. Results of a prospective therapeutic study (author's transl)].
    Chauvergne J; Durand M; Hoerni B; Cohen P; Lagarde C
    Bull Cancer; 1979; 66(1):9-16. PubMed ID: 420953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G; Kratzer H; Denz H; Huber H
    Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination therapy of local tumour recurrence in patients with breast cancer (author's transl)].
    Szepesi T; Sabitzer H; Sabitzer G
    Wien Klin Wochenschr; 1979 Jan; 91(1):15-8. PubMed ID: 425521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination chemotherapy of anaplastic carcinoma with adriamycin, vincristine, methotrexate and cyclophosphamide (author's transl)].
    Chauvergne J; Durand M; Hoerni B; Brunet R; Bui BN
    Bull Cancer; 1980; 67(2):167-74. PubMed ID: 7448439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination treatment of localised breast cancers with a high risk of metastatic disease. The results of a prospective controlled study (author's transl)].
    Chauvergne J; Durand M; Richaud P; Avril A; Hoerni B; Lagarde C
    J Gynecol Obstet Biol Reprod (Paris); 1981; 10(1):75-85. PubMed ID: 7019300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for breast cancer.
    Allegra JC; Lippman ME
    Compr Ther; 1979 Feb; 5(2):13-7. PubMed ID: 428200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytostatic therapy in metastasizing breast cancer].
    Gynning I; Mattsson W
    Lakartidningen; 1978 Apr; 75(15):1512-5. PubMed ID: 651418
    [No Abstract]   [Full Text] [Related]  

  • 8. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
    Brown I; Ward HW
    Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
    [No Abstract]   [Full Text] [Related]  

  • 9. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polychemotherapy of advanced breast cancer. Triple combination with doxorubicin. Analysis of 209 observation].
    Chauvergne J; Gary-Bobo J; Klein T; Guerrin J; Brulé G; Clavel B; Pommatau E; Carton M; Berlie J
    Bull Cancer; 1977; 64(4):667-80. PubMed ID: 343839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F; Alberto P; Jungi F; Brunner K; Martz G
    Eur J Cancer (1965); 1980; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract]   [Full Text] [Related]  

  • 13. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)].
    Mayr AC; Senn HJ; Gallmeier WM; Bruntsch U; Becher R; Drings P; Fritze D; Kaufmann M; Queisser W; Kempgens U
    Dtsch Med Wochenschr; 1979 Dec; 104(49):1739-43. PubMed ID: 510206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary curative treatment for disseminated carcinoma of the breast.
    Mannes P; Derriks R; Moens R; Laurent C; Dalcq JM
    Cancer Treat Rep; 1976 Jan; 60(1):85-9. PubMed ID: 1000521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
    Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
    Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antineoplastic chemotherapy of head and neck tumors (author's transl)].
    Weidauer H
    HNO; 1981 Nov; 29(11):374-80. PubMed ID: 6171551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First, second and third line chemotherapy programs in metastatic breast carcinoma.
    Rizel S; Sulkes A; Gez E; Brufman G; Biran S
    Isr J Med Sci; 1981; 17(9-10):946-53. PubMed ID: 6171542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
    Pannuti F; Iafelice G; Martoni A; Fruet F; Angelelli B; Casadei M
    Chemioterapia; 1984 Aug; 3(4):216-9. PubMed ID: 6398121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.